Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|January 21, 2016
A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated LipodystrophyAlka Deshpande, Harsh Toshniwal, Shashank Joshi, et al.
Diabetes Technology & Therapeutics|October 22, 2013
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI)Rajendrakumar H Jani, Vikas Pai, Pramod Jha, et al.
Journal of Diabetes Science and Technology|May 31, 2014
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)Vikas Pai, A Paneerselvam, Satinath Mukhopadhyay, et al.
International Journal of Rheumatic Diseases|July 16, 2015
A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritisRajendrakumar H Jani, Rajiv Gupta, Girish Bhatia, et al.
Pageof 1